- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03064724
Practice-based Intervention for Vietnamese and Korean Patients
22 février 2017 mis à jour par: Thu Quach, Asian Health Services
This pilot project examined the feasibility of an multilingual interactive video education intervention "an interactive Mobile Doctor intervention (iMD)" to promote patient-provider discussion on tobacco use for Korean- and Vietnamese-speaking male patients at primary care settings.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
While California has made significant strides in tobacco control and is leading the nation in reducing smoking use, the decline is not observed in all groups.
Select groups still have much higher smoking rates and thus bear an unequal burden of tobacco-related illnesses and deaths.
Of important note, Asian American men as a combined group have a higher smoking rate than non-Hispanic Whites (22% vs. 18%, respectively); in particular, the highest smoking prevalence has been observed in Vietnamese (31%) and Korean (30%) men among major Asian subgroups.
Research also shows that smoking rates are higher for Asian American men with low acculturation (e.g., immigrant status, low English proficiency) than for those who are more acculturated; yet the reverse trend is observed in Asian American women.
These findings underscore the need for more targeted tobacco control efforts.
The scientific literature suggests that provider advice to quit smoking can influence a smoker's decision to quit.
However, research has shown that Asian Americans are less likely to receive such provider advice.
Providers often have very limited face-time with patients during the short clinic visit, which presents a challenge as to whether they can incorporate smoking cessation messages during the visit.
Overall, little research has focused on smoking cessation in the clinic setting, particularly research that focuses on Asian Americans.
The purpose of the pilot study was to develop a more streamlined smoking cessation intervention that can be integrated into the clinic visit, especially to maximize the time when patients are waiting to see their providers.
The research question was whether providing culturally appropriate video education that includes provider advice and was tailored to a patient's readiness for quitting smoking will increase whether a patient receives smoking cessation education according to the recommended Clinical Practice Guideline and whether this results in a decrease in tobacco use in low-income Vietnamese and Korean patients.
Using a community-based participatory research approach, the investigators created the iMD that delivers tailored in-language video messages via a mobile tablet to Korean and Vietnamese male smokers right before their clinic visit with a provider.
iMD delivers the "5 A's" and generates a bilingual tailored printout.
Participants were Korean- and Vietnamese-speaking patients who self-identify as daily smokers and receive primary care at a federally-qualified health center.
This study evaluated the feasibility and acceptability of iMD from the patients' perspectives.
This study examined patient-provider discussion on tobacco use from patients' self-report and electronic health record (EHR), and self-reported quit attempts and smoking abstinence at 3 months post iMD visit.
Type d'étude
Interventionnel
Inscription (Réel)
47
Phase
- N'est pas applicable
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans à 75 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Homme
La description
Inclusion Criteria:
- current smokers identified on electronic health records (EHR)
- have a scheduled primary care visit during the recruitment period
Exclusion Criteria:
- already quit smoking or not smoking daily in the past 7 days
- had already quit smoking or not smoking daily in the past 7 days
- had canceled or rescheduled their primary care visit outside of the study period
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Smoking Cessation Group
Patients received the interactive mobile doctor (iMD) intervention.
|
iMD delivers tailored interactive video education via a mobile tablet to smoking patients right before their clinic visit with a provider.
iMD delivers the "5 A's" (ask, advise, assess, assist, and arrange) and generates a bilingual tailored printout, which aims to increase patient-provider discussion on tobacco use and to promote smoking cessation.
This version of iMD delivers the intervention in Korean or Vietnamese languages as preferred by the patient.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Participation Rate
Délai: Baseline
|
proportion of eligible participants consent to participate
|
Baseline
|
|
Acceptability
Délai: through study completion, an average of 1 year
|
proportion of participants who rated the intervention as moderately to extremely satisfied
|
through study completion, an average of 1 year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Patient-provider discussion
Délai: "through study completion, an average of 1 year
|
self-reported by patient whether discussion on tobacco use took place at the indexed clinical encounter
|
"through study completion, an average of 1 year
|
|
Physician delivery of 5As
Délai: "through study completion, an average of 1 year
|
EHR-documented physician's delivery of assess, advice, assist, or arrange at the indexed clinical encounter
|
"through study completion, an average of 1 year
|
|
Quit attempt
Délai: 3-month
|
self-reported at least one or more 24 hour quit attempts
|
3-month
|
|
Abstinence
Délai: 3-month
|
self-reported 7-day point prevalent smoking abstinence
|
3-month
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Thu Quach, PhD, MPH, Asian Health Services
- Chercheur principal: Janice Tsoh, University of California, San Francisco
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 août 2012
Achèvement primaire (Réel)
1 juillet 2015
Achèvement de l'étude (Réel)
1 juillet 2015
Dates d'inscription aux études
Première soumission
20 février 2017
Première soumission répondant aux critères de contrôle qualité
22 février 2017
Première publication (Réel)
27 février 2017
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
27 février 2017
Dernière mise à jour soumise répondant aux critères de contrôle qualité
22 février 2017
Dernière vérification
1 février 2017
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 21BT-0056
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .